PPD

444 articles about PPD

• PPD Expands Special Patient Capabilities in Early Development Research

  12/3/2019

  Enhancing its ability to conduct complex, procedurally intensive Phase I and Phase Ib early development clinical research in neurology, PPD has added a 52-bed CRU in Orlando, Florida.

• PPD Receives Patient First Award at Medidata NEXT

  11/27/2019

  Recognized for commitment to decreasing patient burden in clinical trials

• PPD Announces Confidential Submission of Draft Registration Statement for Proposed Initial Public Offering

  11/12/2019

  The initial public offering is expected to commence after the SEC completes its review process, subject to market and other conditions.

• PPD’s SiteCoach Training to Enable More Health Care Providers to Conduct Clinical Trials

  10/30/2019

  Providing new patient treatment options, accelerating development of life-changing medicines

• PPD Repeats as Best CRO at World ADC Awards for Advancing Cancer Research

  10/17/2019

  This recognition affirms the excellence and dedication of PPD® Laboratories professionals in helping advance clients’ antibody-drug conjugate (ADC) research to develop new anticancer therapies.

• PPD Expanding Bioanalytical Laboratory Capabilities

  9/19/2019

  Enhancing immunochemistry, biomarker and chromatography services for biopharma clients

• Evidera and CSS Collaborate to Develop Joint Real-world and Patient-centered Research Capabilities in Japan

  8/21/2019

  Evidera, a business unit of Pharmaceutical Product Development, LLC (PPD), has entered into an exclusive collaboration agreement with Clinical Study Support, Inc. (CSS), a subsidiary of Shin Nippon Biomedical Laboratories Ltd. (SNBL), extending both organizations’ capabilities to deliver more robust consulting and analytical capabilities and creating a more complete geographic customer solution for clinical, real-world and patient-centered research.

• Optimal Just-in-Time Service Changing the Paradigm of Cancer Trials

  7/16/2019

  First-patient-in milestone achieved in only two weeks with Cancer Treatment Centers of America

• PPD Recognized for Exceptional Quality of Collaboration with Clinical Research Sites

  4/25/2019

  Strong site relationships key to quality execution, on-time delivery for biopharmaceutical customers

• PPD Named One of America’s Best Large Employers by Forbes

  4/17/2019

  The recognition follows PPD’s inclusion earlier this year on Forbes’ list of America’s Best Employers for Diversity.

• 

  Bio NC Hotbed Region: Over 100% Growth This Century

  3/26/2019

  Anchored by Raleigh, Durham and the Research Triangle Park region, BioSpace’s Bio NC Hotbed is one of the faster-growing areas for biopharma in the U.S.

• Forbes Recognizes PPD as One of America's Best Employers for Diversity

  1/15/2019

  Pharmaceutical Product Development, LLC (PPD), a leading global contract research organization dedicated to improving health, has been named to Forbes magazine’s 2019 list of America’s Best Employers for Diversity

• PPD® Laboratories’ Scientist Recognized as Rising Star

  11/12/2018

  Jing Tu has been selected as the 2018 winner of the Bioanalysis Rising Star Award, selected from among 30 nominees across the globe.

• PPD Receives Medidata Accelerator Award for Clinical Trial Innovation

  10/25/2018

  Award recognizing PPD’s commitment to innovation for advancing and accelerating the drug development process.

• 

  Gotham Therapeutics Launches in New York City with $54 Million Series A Financing

  10/10/2018

  Gotham Therapeutics launched in New York with a $54 million Series A financing. The focus is on a subgroup of RNA metabolism called epitranscriptomics. This involves the biochemical modifications of RNA within a cell, which have an impact on gene expression.

• PPD and NeoGenomics Forming Global Strategic Alliance for Pathology and Molecular Testing Solutions

  6/1/2018

  Expanding Global Oncology Testing for Clinical Trials

• PPD Expands GMP Biologics Testing Capacity

  3/28/2018

  Substantially Increases Ability to Support Large Molecule Development

• PPD and Acurian Introduce Innovative Patient Concierge Service for Clinical Trials

  2/28/2018

  Provides Personalized Support for Patients and Enhances Retention for Clients

• PPD Recognized for Superior Employee Development

  2/21/2018

  Pharmaceutical Product Development, LLC (PPD) today announced it has been honored for employee learning and development programs that help the global contract research organization deliver service excellence to its pharmaceutical and biotechnology clients.

• PPD Names Maria Teresa Hilado, CFO of Allergan, to its Board of Directors

  2/1/2018

  PPD today announced that Maria Teresa Hilado, chief financial officer of Allergan, has been named to PPD’s board of directors.